Concussions are becoming increasingly common, especially among school-age athletes. It has been estimated that there are up to 3.8 million sports-related concussions in the United States each year ...View Article
You are using an outdated browser. Please upgrade your browser to improve your experience.
Posted on 10-28-2017
When exploring medical options for the treatment of opioid addiction, you will find that there are several different options available. Two of these options are Naltrexone and suboxone. Exploring these two options and learning more about what each has to offer will help you to better determine which is right for you.
Known by the brand names of Depade or Revia, naltrexone is an opioid antagonist that blocks the action of opioids. It is not addictive or sedating. Therefore, it does not result in physical dependence. For patients who have a history of failure to comply with treatment, however, naltrexone may not be very effective.
An injectable long-acting formulation of naltrexone known as Vivitrol has received FDA approval for the treatment of opioid addiction. Administered once per month, Vivitrol eliminates the need for daily dosing.
A partial opioid agonist, suboxone was approved by the FDA in 2002. 11 years later, the FDA approved two generic forms of the drug, thereby helping to reduce the cost of its use. Suboxone can be more effective for some patients in that it does not produce the high that is associated with opioid abuse.
Furthermore, if the patient injects suboxone rather than taking it orally, it induces withdrawal symptoms. These effects combined with the fact that it actually helps to reduce drug cravings makes it a good option for many people. To learn more about suboxone and how it might be able to help you or a loved one, contact Advanced Spine & Rehab today.
There are no comments for this post. Please use the form below to post a comment.